Back to All Services
Our Services
Health Economics Research
At Medicys we partner with, and are preferred suppliers to, many leading health economics firms who focus on measuring and valuing the outcomes of healthcare interventions and who seek to understand how to navigate regulatory frameworks and Health Technology Assessment processes.
Specifically, our pricing and market access specialists recruit, interview and report on our network of local, regional and national payers (and ex payers) and Payer Advising Key Opinion Leaders (PA-KOLs) on topics such as:
- Economic Evaluation
- Cost of illness
- Cost comparison, effectiveness, utility and benefit
- Thresholds and opportunity costs
- Value driven healthcare systems
- Health Policy and Regulatory frameworks
- Approval and labelling
- Pricing Policy and pricing Schemes
- Reimbursement and access
- Insurance systems and national healthcare
- Public spending and national health expenditures
- Procurement systems
- Risk sharing approaches
- Health Technology Assessment
- Systems and structure
- Value framework and dossier format
- Decisions and deliberative processes
Our projects in this discipline usually take the form of Web Assisted Telephone Depth Interviews (WATDIs), online groups or advisory boards (digital or in person).
Related Work
See all Work
health economics research
To establish a price point for a new product in both the neoadjuvant and adjuvant setting for melanoma
health economics research
To understand decision making around the guidance on the use of specific anticoagulants within HCPs integrated care systems (ICSs)
health economics research
Hepatocellular carcinoma
To identify challenges with value narrative and provide recommendations regarding how to strengthen the value messages and/or communication of the supportive evidence-base to overcome potential challenges with securing reimbursement of the product.
health economics research
Understand how pharmacists manage their day to day pharmacy dispensing activities, managing high cost prescription drugs, to understand drivers/motivators for dispensing such drugs when there is an originator and a generic, such as drugs for rare diseases
Request a quote
